日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tetrahydropyrido[4,3-d]pyrimidines as a new active scaffold for human topoisomerase II inhibitors

四氢吡啶并[4,3-d]嘧啶作为人类拓扑异构酶II抑制剂的新型活性骨架

Brindani, Nicoletta; La Serra, Maria Antonietta; Ortega, Jose Antonio; Arencibia, Jose M; Nigro, Michela; Bertozzi, Sine Mandrup; Armirotti, Andrea; Borgogno, Marco; Sissi, Claudia; De Vivo, Marco

Preclinical Development of the Na-K-2Cl Co-transporter-1 (NKCC1) Inhibitor ARN23746 for the Treatment of Neurodevelopmental Disorders.

Na-K-2Cl 共转运蛋白-1 (NKCC1) 抑制剂 ARN23746 用于治疗神经发育障碍的临床前开发

Savardi Annalisa, Patricelli Malizia Andrea, De Vivo Marco, Cancedda Laura, Borgogno Marco

Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders.

发现一种用于选择性抑制NKCC1治疗脑部疾病的小分子候选药物

Savardi Annalisa, Borgogno Marco, Narducci Roberto, La Sala Giuseppina, Ortega Jose Antonio, Summa Maria, Armirotti Andrea, Bertorelli Rosalia, Contestabile Andrea, De Vivo Marco, Cancedda Laura